| __timestamp | Biogen Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 1171036000 | 9136000 |
| Thursday, January 1, 2015 | 1240400000 | 5807000 |
| Friday, January 1, 2016 | 1478700000 | 5571000 |
| Sunday, January 1, 2017 | 1630000000 | 5366000 |
| Monday, January 1, 2018 | 1816300000 | 6337000 |
| Tuesday, January 1, 2019 | 1955400000 | 11347000 |
| Wednesday, January 1, 2020 | 1805200000 | 30419000 |
| Friday, January 1, 2021 | 2109700000 | 62176000 |
| Saturday, January 1, 2022 | 2278300000 | 52827000 |
| Sunday, January 1, 2023 | 2533400000 | 35049000 |
| Monday, January 1, 2024 | 0 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. From 2014 to 2023, Biogen Inc. and Ligand Pharmaceuticals Incorporated have shown distinct trajectories in their cost of revenue. Biogen's cost of revenue has surged by approximately 116%, from $1.17 billion in 2014 to $2.53 billion in 2023. This reflects its expanding operations and increased production costs. In contrast, Ligand Pharmaceuticals, a smaller player, saw its cost of revenue grow by nearly 284%, albeit from a much smaller base, reaching $35 million in 2023. This dramatic increase highlights Ligand's strategic shifts and scaling efforts. The data underscores the contrasting scales and growth strategies of these two companies, offering valuable insights into their financial health and operational strategies over the past decade.
Cost of Revenue: Key Insights for Novo Nordisk A/S and Biogen Inc.
Novo Nordisk A/S vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down AbbVie Inc. and Biogen Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Pfizer Inc. vs Ligand Pharmaceuticals Incorporated
Comparing Cost of Revenue Efficiency: Biogen Inc. vs United Therapeutics Corporation
Cost of Revenue Comparison: Biogen Inc. vs Bio-Techne Corporation
Cost of Revenue Comparison: Biogen Inc. vs Iovance Biotherapeutics, Inc.
Comparing Cost of Revenue Efficiency: Biogen Inc. vs Wave Life Sciences Ltd.
Biogen Inc. or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Biogen Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Amneal Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated
Analyzing Cost of Revenue: Veracyte, Inc. and Ligand Pharmaceuticals Incorporated